| Trial ID: | L0462 |
| Source ID: | IRCT20190714044196N1
|
| Associated Drug: |
Berberis
|
| Title: |
The effect of hydroalcoholic extract of Berberis fruits integerrima on the lipid profile, antioxidantparameters and liver and kidney function tests in patients with nonalcoholic fatty liver disease
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Nonalcoholic fatty liver. <br>Fatty (change of) liver, not elsewhere classified;K76.0
|
| Interventions: |
Intervention 1: Intervention group: received a gelatin capsule contain 750 mg hydro-alcoholic extract of Berberis integerrima . Berberis fruits were taken from mountainous areas of Bardsir, Kerman, Southeast of Iran and confirmed by Iranian institute of r
|
| Outcome Measures: |
Fasting blood glucose. Timepoint: Before and after treatment. Method of measurement: measured using Pars azmun kit.;Total cholesterol. Timepoint: Before and after treatment. Method of measurement: measured using Pars azmun kit.;Triglyceride. Timepoint: Before and after treatment. Method of measurement: measured using Pars azmun kit.;LDL-C. Timepoint: Before and after treatment. Method of measurement: measured using Pars azmun kit.;HDL-C. Timepoint: Before and after treatment. Method of measurement: measured using Pars azmun kit.;Alanine aminotransferase. Timepoint: Before and after treatment. Method of measurement: measured using Pars azmun kit.;Aspartate aminotransferase. Timepoint: Before and after treatment. Method of measurement: measured using Pars azmun kit.;Alkaline phosphatase. Timepoint: Before and after treatment. Method of measurement: measured using Pars azmun kit.;Total bilirubin. Timepoint: Before and after treatment. Method of measurement: measured using Pars azmun kit.;And direct bilirubin. Timepoint: Before and after treatment. Method of measurement: measured using Pars azmun kit.;Urea. Timepoint: Before and after treatment. Method of measurement: measured using Pars azmun kit.;Creatinine. Timepoint: Before and after treatment. Method of measurement: measured using Pars azmun kit.;Glutathione peroxidase enzyme. Timepoint: Before and after treatment. Method of measurement: ZellBio kit.;Malondialdehyde. Timepoint: Before and after treatment. Method of measurement: ZellBio kit.;Total antioxidant. Timepoint: Before and after treatment. Method of measurement: ZellBio kit.;Blood pressure. Timepoint: Before and after treatment. Method of measurement: Blood pressure monitor.nan
|
| Sponsor/Collaborators: |
Rafsanjan University of Medical Sciences
|
| Gender: |
All
|
| Age: |
20 years45 years
|
| Phases: |
Phase 3
|
| Enrollment: |
42
|
| Study Type: |
interventional
|
| Study Designs: |
Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Patients separated to two groups, randomly using table of random numbers, Blinding description: Participant (patients
|
| Start Date: |
31/07/2019
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
7 October 2019
|
| Locations: |
Iran (Islamic Republic of)
|
| URL: |
http://en.irct.ir/trial/40780
|
